Showing results (801-810 of 942) with videos related to
Sort By:
Pageof 95
Journal of the American College of Cardiology|September 4, 2024
Heart Failure Risk Assessment Using Biomarkers in Patients With Atrial Fibrillation: Analysis From COMBINE-AFPaul M Haller, Petr Jarolim, Michael G Palazzolo, et al.European Journal of Heart Failure|December 22, 2023
Natriuretic peptides, body mass index and heart failure risk: Pooled analyses of SAVOR-TIMI 53, DECLARE-TIMI 58 and CAMELLIA-TIMI 61Siddharth M Patel, David A Morrow, Andrea Bellavia, et al.Circulation|September 6, 2014
Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trialBenjamin M Scirica, Eugene Braunwald, Itamar Raz, et al.Circulation|September 1, 2016
Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54)Marc P Bonaca, Shinya Goto, Deepak L Bhatt, et al.European Heart Journal. Acute Cardiovascular Care|January 5, 2022
End-of-life care in the cardiac intensive care unit: a contemporary view from the Critical Care Cardiology Trials Network (CCCTN) RegistryAntonio Fagundes, David D Berg, Erin A Bohula, et al.Journal of the American Heart Association|May 6, 2017
Ranolazine in Symptomatic Diabetic Patients Without Obstructive Coronary Artery Disease: Impact on Microvascular and Diastolic FunctionNishant R Shah, Michael K Cheezum, Vikas Veeranna, et al.Drug Safety|November 25, 2018
Diagnostic Algorithms for Cardiovascular Death in Administrative Claims Databases: A Systematic ReviewSonal Singh, Hassan Fouayzi, Kathryn Anzuoni, et al.Circulation|June 23, 2025
Abelacimab Versus Rivaroxaban in Patients With Atrial Fibrillation on Antiplatelet Therapy: A Prespecified Analysis of the AZALEA-TIMI 71 TrialSamer Al Said, Siddharth M Patel, Robert P Giugliano, et al.JAMA Cardiology|February 4, 2026
Abelacimab vs Rivaroxaban in Older Individuals With Atrial Fibrillation: A Prespecified Analysis of the Phase 2b AZALEA-TIMI 71 TrialSamer Al Said, Siddharth M Patel, Robert P Giugliano, et al.American Heart Journal|July 2, 2019
Changes in comorbidities, diagnoses, therapies and outcomes in a contemporary cardiac intensive care unit populationJacob C Jentzer, Sean van Diepen, Gregory W Barsness, et al.Pageof 95